» Tasneem Naqvi, M.D

Follow us:    

Open/Close Menu

1877-SHAPE11

Skip to content

Home
About SHAPE
Physicians
Gallery
News and Events
Provider Locator

Donate or Volunteer

SHAPE Presentations

AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
Date: Mon Jan 8 4:33

AHA SHAPE Symposium 2017 Dr. Kloner Presentation
Date: Mon Jan 8 4:32

AHA SHAPE Symposium 2017 Dr. Greenland Presentation
Date: Mon Jan 8 4:31

AHA SHAPE Symposium 2017 Dr. Yen Presentation
Date: Mon Jan 8 4:30

AHA SHAPE Symposium 2017 Dr. Slomka Presentation
Date: Mon Jan 8 4:27

Vu lplaque1 pasterkamp
Date: Mon Sep 19 19:32

Vulnerable plaque vulnerable patient
Date: Mon Sep 19 19:32

Vulnerable plaque overview
Date: Mon Sep 19 19:32

Vulnerable patient talk in poland
Date: Mon Sep 19 19:32

Vulnerable patient slides without movies
Date: Mon Sep 19 19:32

Vulnerable patient slides with movies
Date: Mon Sep 19 19:32

Vulnerable patient mar 04
Date: Mon Sep 19 19:32

Vulnerable (thrombogenic blood
Date: Mon Sep 19 19:32

Vuln shape aha 2005
Date: Mon Sep 19 19:32

Vuln plaque poster burke
Date: Mon Sep 19 19:32

Vp watch editorial_slide 25short-
Date: Mon Sep 19 19:32

Vp watch editorial_slide25
Date: Mon Sep 19 19:32

Vp watch editorial_slide25short-
Date: Mon Sep 19 19:32

Vp watch2002
Date: Mon Sep 19 19:32

Vp symposium31602
Date: Mon Sep 19 19:32

Vpschoenhagen
Date: Mon Sep 19 19:32

Vp meeting orlando2003_new template
Date: Mon Sep 19 19:32

Vpiii lobby-02
Date: Mon Sep 19 19:32

Vp
Date: Mon Sep 19 19:32

Vp.org cimit harvard
Date: Mon Sep 19 19:32

Vp texas by yuan
Date: Mon Sep 19 19:32

Vp watch editorial - v2 n3- 2002
Date: Mon Sep 19 19:32

Vp watch editorial - v2 n2- 2002
Date: Mon Sep 19 19:32

Vp watch editorial - v2 n6- 2002
Date: Mon Sep 19 19:32

Vp watch editorial - v2 n4- 2002
Date: Mon Sep 19 19:32

Vp symposium 3 16-02
Date: Mon Sep 19 19:32

Vp schoenhagen
Date: Mon Sep 19 19:32

Vp slides
Date: Mon Sep 19 19:32

Vp presentation jar 3 29 03
Date: Mon Sep 19 19:32

Vp paper 7 pics (aeha logo)
Date: Mon Sep 19 19:32

Vp lightlab kolstad (industry)
Date: Mon Sep 19 19:32

Vp 2002 talk show copy galis
Date: Mon Sep 19 19:32

Voorbeeld3 dhisto
Date: Mon Sep 19 19:32

Volcano avi
Date: Mon Sep 19 19:32

Visualization of atherosclerotic vulnerable plaque
Date: Mon Sep 19 19:32

Vogel endothelial function cv es
Date: Mon Sep 19 19:32

Virmani
Date: Mon Sep 19 19:32

Vascular interventions
Date: Mon Sep 19 19:32

Virella
Date: Mon Sep 19 19:32

Vascular interventions atalar- johns hopkins
Date: Mon Sep 19 19:32

V2n31
Date: Mon Sep 19 19:32

Updated power point presentation of the vulnerable patient manuscript
Date: Mon Sep 19 19:32

Toyotaka
Date: Mon Sep 19 19:32

Transgenic cetp dahl salt sensitive (tg53) rat model
Date: Mon Sep 19 19:32

Towards immune modulation vp
Date: Mon Sep 19 19:32

Tlr4 circulation
Date: Mon Sep 19 19:32

Towards immune modulation vp 16 11 gkh
Date: Mon Sep 19 19:32

Tissue contrast
Date: Mon Sep 19 19:32

Thermographya novel approach for the identification of vp
Date: Mon Sep 19 19:32

Thermography iii
Date: Mon Sep 19 19:32

Thermography early clinical correlations
Date: Mon Sep 19 19:32

Thermo elastography
Date: Mon Sep 19 19:32

The balancee of proteolysis
Date: Mon Sep 19 19:32

Thermal hetrogeneity clinical syndrome 2
Date: Mon Sep 19 19:32

The fat fed apoe ko mouse- chris jackson- u of bristol
Date: Mon Sep 19 19:32

The prevalence of inflammatory cells in non ruptured atherosclerotic plaques
Date: Mon Sep 19 19:32

The prev of inf cells in nonrupt a. plaque pasterkamp- part 2
Date: Mon Sep 19 19:32

The new design basket catheter system
Date: Mon Sep 19 19:32

The entire poster presentation of vp symposium acc 2003
Date: Mon Sep 19 19:32

Tct recognition of vulnerable plaque guidelines
Date: Mon Sep 19 19:32

Tct fat poster-title
Date: Mon Sep 19 19:32

Tct mri 2001
Date: Mon Sep 19 19:32

Tct arrow pics, landscape
Date: Mon Sep 19 19:32

Taylor.aeha cac imt progression talk.1
Date: Mon Sep 19 19:32

Tawakol
Date: Mon Sep 19 19:32

Symposium jang
Date: Mon Sep 19 19:16

Stroes
Date: Mon Sep 19 19:16

Strains vp
Date: Mon Sep 19 19:16

Stephanes talk aeha
Date: Mon Sep 19 19:16

Stenosis vs risk
Date: Mon Sep 19 19:16

Stenosis severity and risk benefit
Date: Mon Sep 19 19:16

Stein cimt for shape 11-05
Date: Mon Sep 19 19:16

Stefanadis
Date: Mon Sep 19 19:16

Statins are associated
Date: Mon Sep 19 19:16

Statin periomort
Date: Mon Sep 19 19:16

Spio mri studies by dr naghavi-presented to ge-amersham
Date: Mon Sep 19 19:16

Spio mri studies by dr naghavi
Date: Mon Sep 19 19:16

Spio mri studies by dr naghavi - presented to ge-amersham
Date: Mon Sep 19 19:16

Spio mri studies by dr naghavi - amersham oct 2003 - part 1
Date: Mon Sep 19 19:16

Spio cytokinejan28
Date: Mon Sep 19 19:16

Spio mri studies by dr naghavi - amersham oct 2003 - part2
Date: Mon Sep 19 19:16

Spio cytokinejan28-2
Date: Mon Sep 19 19:16

Spio uptake by macrophages
Date: Mon Sep 19 19:16

Spio photo
Date: Mon Sep 19 19:16

Spectroscopic fiber optic catheter tania - aha 2001
Date: Mon Sep 19 19:16

Spatial encoding part_2
Date: Mon Sep 19 19:16

Spect ct -dan berman
Date: Mon Sep 19 19:16

Slides 25 28
Date: Mon Sep 19 19:16

Slides 29 38
Date: Mon Sep 19 19:16

Slides naqvi
Date: Mon Sep 19 19:16

Slides 21 24
Date: Mon Sep 19 19:16

Slides 9 20
Date: Mon Sep 19 19:16

Slides 20 37 -vulnerable patient with movies
Date: Mon Sep 19 19:16

Slides 1 20 -vulnerable patient with movies
Date: Mon Sep 19 19:16

Slides 1 8
Date: Mon Sep 19 19:16

Slides2938
Date: Mon Sep 19 19:16

Slides2528
Date: Mon Sep 19 19:16

Slides920
Date: Mon Sep 19 19:16

Slides2124
Date: Mon Sep 19 19:16

Slides18
Date: Mon Sep 19 19:16

Slagerperspective
Date: Mon Sep 19 19:16

Slide shows of uptake of spio by macrophages and monocytes10
Date: Mon Sep 19 19:16

Slager1
Date: Mon Sep 19 19:16

Silvio flu
Date: Mon Sep 19 19:16

Shuzou
Date: Mon Sep 19 19:16

Silvio sept 24
Date: Mon Sep 19 19:16

Shoenhagen
Date: Mon Sep 19 19:16

Shape a-thon clinton
Date: Mon Sep 19 19:16

Shape symposium slide presentation
Date: Mon Sep 19 19:16

Shape aha 2005
Date: Mon Sep 19 19:16

Seferovic
Date: Mon Sep 19 19:16

Shah vaccine
Date: Mon Sep 19 19:16

Schwartz debate aha 2002
Date: Mon Sep 19 19:16

Scd
Date: Mon Sep 19 19:16

Saloner presentation
Date: Mon Sep 19 19:16

Rumberger vp discussion 11 03
Date: Mon Sep 19 19:16

Rumberger 2nd vp symposium 3 6 04
Date: Mon Sep 19 19:16

Rumberger
Date: Mon Sep 19 19:16

Rumberg 4
Date: Mon Sep 19 19:16

Rumberg3
Date: Mon Sep 19 19:16

Revisiting the basics culprit vs non culprit
Date: Mon Sep 19 19:16

Revisiting the basics culprit vs non culprit
Date: Mon Sep 19 19:16

Rumberg1
Date: Mon Sep 19 19:16

Ricenano
Date: Mon Sep 19 19:16

Resp infection of apoe ko mice and plaque inflammation
Date: Mon Sep 19 19:16

Rumberg2
Date: Mon Sep 19 19:16

Research findings
Date: Mon Sep 19 19:16

Recent results and findings.
Date: Mon Sep 19 19:16

Progress with the a 3 fr nir fiber optic catheter
Date: Mon Sep 19 19:16

Pulse sequences gradient echo
Date: Mon Sep 19 19:16

Project introduction
Date: Mon Sep 19 19:16

Preset3
Date: Mon Sep 19 19:16

Presentation1
Date: Mon Sep 19 19:16

Ppt for adelson sketch
Date: Mon Sep 19 19:16

Positive remodeling slides for ralph
Date: Mon Sep 19 19:16

Positive remodeling for ralph
Date: Mon Sep 19 19:16

Polymophism in the promoter
Date: Mon Sep 19 19:16

Plaque petct
Date: Mon Sep 19 19:16

Pharmacologic treatment of vulnerable plaque
Date: Mon Sep 19 19:16

Plaque rupture definition
Date: Mon Sep 19 19:16

Plaque severity and coronary occlusion
Date: Mon Sep 19 19:16

Plaque inflammation july 2
Date: Mon Sep 19 19:16

Percutaneous coronary intervention
Date: Mon Sep 19 19:16

Plaque inflammation in atherosclerotic rabbits
Date: Mon Sep 19 19:16

Patrick updown
Date: Mon Sep 19 19:16

Plaque characterization with oct
Date: Mon Sep 19 19:16

Phil graham new
Date: Mon Sep 19 19:16

Peter libby, md
Date: Mon Sep 19 19:16

Periadventitial fat
Date: Mon Sep 19 19:16

Percutaneouse
Date: Mon Sep 19 19:16

Pbg vp mar02_final
Date: Mon Sep 19 19:16

Percutaneous coronary intervention by hossein
Date: Mon Sep 19 19:16

Percutaneouse coronary intervention
Date: Mon Sep 19 19:16

Pasterkamp1
Date: Mon Sep 19 19:16

Pasterkamp2
Date: Mon Sep 19 19:16

Pasterkamp
Date: Mon Sep 19 19:16

Pandemic of cvd atlanta
Date: Mon Sep 19 19:16

Out of hospital
Date: Mon Sep 19 19:16

Pancoronary therapy with ipdd
Date: Mon Sep 19 19:16

Out of hospital sudden cardiac death (scd) declining or escalating
Date: Mon Sep 19 19:16

Out of hospital sudden cardiac death(scd)
Date: Mon Sep 19 19:16

Out of hospital 2
Date: Mon Sep 19 19:16

Optical coherence tomography optical biopsy with a short photonic needle
Date: Mon Sep 19 19:16

Optic
Date: Mon Sep 19 19:16

Optical coherence tomography jang-mgh
Date: Mon Sep 19 19:16

Old vulnerable patient slides without movies
Date: Mon Sep 19 19:16

Old vulnerable patient slides with movies
Date: Mon Sep 19 19:16

Oct with shourt phontonic needle
Date: Mon Sep 19 19:16

Noninvasive mr imaging of plaque inflammation
Date: Sat Sep 17 22:42

Non invasive imaging of the vulnerable plaque and the vulnerable patient ge imatron
Date: Sat Sep 17 22:42

Non invasive detection of vulnerable plaque 2
Date: Sat Sep 17 22:42

Non enhancement mri of rabbit1
Date: Sat Sep 17 22:42

Non invasive detection of vulnerable plaque using spio enhanced mri
Date: Sat Sep 17 22:42

Nmr intro1
Date: Sat Sep 17 22:42

Nitrate tolerance
Date: Sat Sep 17 22:42

Nmr relaxation times
Date: Sat Sep 17 22:42

Nirs
Date: Sat Sep 17 22:42

Nih ppg 9-021
Date: Sat Sep 17 22:42

Nir near to far slides lodder
Date: Sat Sep 17 22:42

Nir spectroscopy lodder- u of kentucky
Date: Sat Sep 17 22:42

Nir poster
Date: Sat Sep 17 22:42

New insight to vp plaque imaging cvpr
Date: Sat Sep 17 22:42

Nir catheter final
Date: Sat Sep 17 22:42

Nir near to far from our expectations
Date: Sat Sep 17 22:42

Nilssonetal
Date: Sat Sep 17 22:42

Nilsson
Date: Sat Sep 17 22:42

Navab's an oral hdl
Date: Sat Sep 17 22:42

Nih ppg 9-02
Date: Sat Sep 17 22:42

New insights into vulnerable plaque
Date: Sat Sep 17 22:42

New thermography catheters
Date: Sat Sep 17 22:42

New advances in thermography
Date: Sat Sep 17 22:42

Near infrared spectroscopy 2
Date: Sat Sep 17 22:42

Navab hdl
Date: Sat Sep 17 22:42

Naghavi
Date: Sat Sep 17 22:42

Naghavi cimit feb12-2002
Date: Sat Sep 17 22:42

My talk at tct04
Date: Sat Sep 17 22:42

Mri spio
Date: Sat Sep 17 22:42

Mri system block diagram
Date: Sat Sep 17 22:42

Mri of atherosclerotic plaque in apo e ko mice
Date: Sat Sep 17 22:42

Mri applications in cardiovascular medicine
Date: Sat Sep 17 22:42

Mri blush sing
Date: Sat Sep 17 22:42

Mr images of human carotid arteries
Date: Sat Sep 17 22:42

Morrisett
Date: Sat Sep 17 22:42

Mr contrast agents for vp imaging philip graham
Date: Sat Sep 17 22:42

Moreno mort meeting
Date: Sat Sep 17 22:42

Moreno.nir vp.org acc02
Date: Sat Sep 17 22:42

Monocyte recruitment into atherosclerotic plaques
Date: Sat Sep 17 22:42

Molecular genetics
Date: Sat Sep 17 22:42

Mol gen-1
Date: Sat Sep 17 22:42

Micro array study for gene expression in vp
Date: Sat Sep 17 22:42

Mn aha 05
Date: Sat Sep 17 22:42

Mice and rabbits mri files
Date: Sat Sep 17 22:42

Mi or scd in patients with very abnormal cardiac test results
Date: Sat Sep 17 22:42

Maziar2
Date: Sat Sep 17 22:42

Masanori aikawa powerpoint
Date: Sat Sep 17 22:42

Mallat
Date: Sat Sep 17 22:42

Macrophage uptake of cns1 1 d ( in vitro study)
Date: Sat Sep 17 22:42

Macrophage apoptosis
Date: Sat Sep 17 22:42

Macrophage induced proteolysis zorina galis- emory u
Date: Sat Sep 17 22:42

Mace
Date: Sat Sep 17 22:42

Lodder
Date: Sat Sep 17 22:42

Litovsky1
Date: Sat Sep 17 22:42

Life sight
Date: Sat Sep 17 22:42

Libby
Date: Sat Sep 17 22:42

Lecture vienna september 16 2005
Date: Sat Sep 17 22:42

Kwong
Date: Sat Sep 17 22:42

Kuiper
Date: Sat Sep 17 22:42

Kritharides
Date: Sat Sep 17 22:42

Krucoff infra redx_aha_2002_x2
Date: Sat Sep 17 22:42

Koenig aeha2005 short
Date: Sat Sep 17 22:42

Killer of human beings in the century
Date: Sat Sep 17 22:42

Jay cohn md aha 04 aeha conf
Date: Sat Sep 17 22:42

Introduction to nuclear magnetic resonance
Date: Sat Sep 17 22:42

Introduction to mri
Date: Sat Sep 17 22:42

Introducing a novel model
Date: Sat Sep 17 22:42

Intravascular mri diagnostic and therapeutic potentials
Date: Sat Sep 17 22:42

Intravascular elastography
Date: Sat Sep 17 22:42

Intravascular micro bolometer catheter thi
Date: Sat Sep 17 22:42

Intramural delivery of recombinant
Date: Sat Sep 17 22:42

Interleukin 1, tissue necrosis factor-, and interferon- increase spio accumulation
Date: Sat Sep 17 22:42

Influenza infection
Date: Sat Sep 17 22:42

Inhibitory effect on arterial injury induced neointimal formation by adoptive b cell transfer in rag-1 ko mice nilssonetal
Date: Sat Sep 17 22:42

Influenza infection exerts prominent
Date: Sat Sep 17 22:42

Histopathological results of spio distribution in mice (after 24hs)
Date: Sat Sep 17 22:42

Inflammation is not specific to culprit lesion
Date: Sat Sep 17 22:42

In vivo mri of thrombi in advanced atherosclerosis
Date: Sat Sep 17 22:42

Identifying new biomarkers
Date: Sat Sep 17 22:42

Immunisatie1
Date: Sat Sep 17 22:42

Imi beta-probe-vp-sound
Date: Sat Sep 17 22:42

Imaging plaque inflammation crt
Date: Sat Sep 17 22:42

Human carotid mri spio presentation files
Date: Sat Sep 17 22:42

How the world dies today
Date: Sat Sep 17 22:42

How can we identify the plaque at risk of rupture or thrombosis
Date: Sat Sep 17 22:42

How the world dies 1st
Date: Sat Sep 17 22:42

Histopathology and macropahge complete
Date: Sat Sep 17 22:42

Histopathologic study of spio distribution in mice (method)
Date: Sat Sep 17 22:42

Herrera
Date: Sat Sep 17 22:42

Histopathologic study method
Date: Sat Sep 17 22:42

Heart dialysis system
Date: Sat Sep 17 22:42

Hartmut
Date: Sat Sep 17 22:42

Hartmut hanke
Date: Sat Sep 17 22:42

Harvey hecht md aeha sat
Date: Sat Sep 17 22:42

Harats
Date: Sat Sep 17 22:42

Goldschmidt1
Date: Sat Sep 17 22:42

Gene array study of vp
Date: Sat Sep 17 22:42

Genetic influence ppt11
Date: Sat Sep 17 22:42

Genomic and proteomic screen
Date: Sat Sep 17 22:42

Future generations
Date: Sat Sep 17 22:42

Fuster aha-2005-dallas-biomarkers,
Date: Sat Sep 17 22:42

Frequencies in sudden
Date: Sat Sep 17 22:42

From pneumonia to influenza
Date: Sat Sep 17 22:42

Forstermann
Date: Sat Sep 17 22:42

For vp texas by yuan
Date: Sat Sep 17 22:42

For suzy carotid mri-dr willersons book
Date: Sat Sep 17 22:42

Final clickable pps for vp s ymposium aha 2001
Date: Sat Sep 17 22:42

Final clickable pps for vp s ymposium @aha 2001
Date: Sat Sep 17 22:42

For mark shape textbook coverpage
Date: Sat Sep 17 22:42

For print vulnerable patient slides
Date: Sat Sep 17 22:42

For elring 2
Date: Sat Sep 17 22:42

Figuresforpaper 3
Date: Sat Sep 17 22:42

Figuresforpaper robkrams
Date: Sat Sep 17 22:42

Falk, final talk
Date: Sat Sep 17 22:42

Fernandes
Date: Sat Sep 17 22:42

Falk, shape aha 05, final
Date: Sat Sep 17 22:42

Falk
Date: Sat Sep 17 22:42

Existing intravascular imaging technology for plaque characterization
Date: Sat Sep 17 22:42

Everybody has atherosclerosis
Date: Sat Sep 17 22:42

Es v2n46
Date: Wed Sep 14 6:36

E sv2n12
Date: Wed Sep 14 6:36

Es v2n50
Date: Wed Sep 14 6:36

Everybody has atherosclerosis
Date: Wed Sep 14 6:36

Es v2n44
Date: Wed Sep 14 6:36

Es v2n45
Date: Wed Sep 14 6:36

Es v2n43
Date: Wed Sep 14 6:36

Es v2n16
Date: Wed Sep 14 6:36

Es v2n19
Date: Wed Sep 14 6:36

Es v2n17
Date: Wed Sep 14 6:36

Esv3n13
Date: Wed Sep 14 6:36

Esv3 n14
Date: Wed Sep 14 6:36

Esv3n12
Date: Wed Sep 14 6:36

Esv3n11
Date: Wed Sep 14 6:36

Esv3n10
Date: Wed Sep 14 6:36

Esv3n7
Date: Wed Sep 14 6:36

Esv3n5
Date: Wed Sep 14 6:36

Esv3n6
Date: Wed Sep 14 6:36

Esv3n3
Date: Wed Sep 14 6:36

Esv3n4
Date: Wed Sep 14 6:36

Esv2n51
Date: Wed Sep 14 6:36

Esv3n2
Date: Wed Sep 14 6:36

Esv3n1
Date: Wed Sep 14 6:36

Esv2n49
Date: Wed Sep 14 6:36

Esv2n47
Date: Wed Sep 14 6:36

Esv2n48
Date: Wed Sep 14 6:36

Esv2n42
Date: Wed Sep 14 6:36

Esv2n37 b
Date: Wed Sep 14 6:36

Esv2n39
Date: Wed Sep 14 6:36

Esv2n41
Date: Wed Sep 14 6:36

Esv2n40
Date: Wed Sep 14 6:36

Esv2n36
Date: Wed Sep 14 6:36

Esv2n35
Date: Wed Sep 14 6:36

Esv2n37 a
Date: Wed Sep 14 6:36

Esv2n34
Date: Wed Sep 14 6:36

Esv2n33
Date: Wed Sep 14 6:36

Esv2n32
Date: Wed Sep 14 6:36

Esv2n30
Date: Wed Sep 14 6:36

Esv2n13
Date: Wed Sep 14 6:36

Esv2n29
Date: Wed Sep 14 6:36

Esv2n27
Date: Wed Sep 14 6:36

Esv2n26
Date: Wed Sep 14 6:36

Esv2n28
Date: Wed Sep 14 6:36

Esv2n25
Date: Wed Sep 14 6:36

Esv2n24
Date: Wed Sep 14 6:36

Esv2n23
Date: Wed Sep 14 6:36

Esv2n22
Date: Wed Sep 14 6:36

Esv2n14
Date: Wed Sep 14 6:36

Esv2n21
Date: Wed Sep 14 6:36

Esc macrophage homing
Date: Wed Sep 14 6:36

Esv2n20
Date: Wed Sep 14 6:36

Esv2n15
Date: Wed Sep 14 6:36

Elastography
Date: Wed Sep 14 6:36

Erling's slides for ralph
Date: Wed Sep 14 6:36

Erling falk
Date: Wed Sep 14 6:36

Endothelial function.aha.
Date: Wed Sep 14 6:36

Erbel
Date: Wed Sep 14 6:36

Editorial slidesv2n10
Date: Wed Sep 14 6:36

Endothelial dysfunction screening tct 2003 - 2
Date: Wed Sep 14 6:36

Embolic protection devices yadav- cleveland clinic
Date: Wed Sep 14 6:36

Effect of testosterone on neo intimal plaque development
Date: Wed Sep 14 6:36

Embolic protection devices
Date: Wed Sep 14 6:36

Effect of testosterone on neo intimal plaque development
Date: Wed Sep 14 6:36

Effect of statin on body temperature
Date: Wed Sep 14 6:36

Editorial v2n7
Date: Wed Sep 14 6:36

Ea smac homing-oral
Date: Wed Sep 14 6:36

Editorial of the year
Date: Wed Sep 14 6:36

Editorialslides v2n9
Date: Wed Sep 14 6:36

Editorial38
Date: Wed Sep 14 6:36

Ebt and coronary artery calcium
Date: Wed Sep 14 6:36

Ebt rumberger- ohio state u- part 21
Date: Wed Sep 14 6:36

Ebt calcium score
Date: Wed Sep 14 6:36

Ebt calcium score a clue to invulnerable plaque in vulnerable patients
Date: Wed Sep 14 6:36

Economics of screening for atherosclerosis final
Date: Wed Sep 14 6:36

Ebt rumberger- ohio state u- part 4
Date: Wed Sep 14 6:36

Ebt rumberger- ohio state u- part 3
Date: Wed Sep 14 6:36

Ebt rumberger- ohio state u- part 1
Date: Wed Sep 14 6:36

Ea slipidcoated final july 2
Date: Wed Sep 14 6:36

Eas poster titles final
Date: Wed Sep 14 6:36

Dr naghavi conclusion
Date: Wed Sep 14 3:35

Dr zipes vulnerable patient mar 04
Date: Wed Sep 14 3:35

Dr.yadavemboliz2
Date: Wed Sep 14 3:35

Dropped ismrm2001-mri spio
Date: Wed Sep 14 3:35

Drnaghavi
Date: Wed Sep 14 3:35

Dr maseri aeha_neworleans_mar2004
Date: Wed Sep 14 3:35

Dr naghavi acc04secondv_ppatientsymp_opening_welcome
Date: Wed Sep 14 3:35

Drleakeresearch
Date: Wed Sep 14 3:35

Dr.yadavemboliz2
Date: Wed Sep 14 3:35

Dr.jang@aha2002
Date: Wed Sep 14 3:35

Dr virmani
Date: Wed Sep 14 3:35

Dr stone
Date: Wed Sep 14 3:35

Dr naghavi's slides
Date: Wed Sep 14 3:35

Dr falk's slides part ii
Date: Wed Sep 14 3:35

Dr n's presentation at nano vivo seminar
Date: Wed Sep 14 3:35

Dr koenig
Date: Wed Sep 14 3:35

Dr fuster's slides part i
Date: Wed Sep 14 3:35

Dr falk's slides part i
Date: Wed Sep 14 3:35

Dna microarray application in vp research mehran
Date: Wed Sep 14 3:35

Dog's heart
Date: Wed Sep 14 3:35

Discussion topics
Date: Wed Sep 14 3:35

Dna microarray mehran
Date: Wed Sep 14 3:35

Dna microarray mehran- u of toronto
Date: Wed Sep 14 3:35

Diffuse reflectance nir of plaque intracoronary device
Date: Wed Sep 14 3:35

Diamantopoulos2002
Date: Wed Sep 14 3:35

Diabetes and ccs
Date: Wed Sep 14 3:35

Deteection of vulnerable atherosclerotic plaque by nis
Date: Wed Sep 14 3:35

Detection of vulnerable atherosclerotic plaques by nis
Date: Wed Sep 14 3:35

Detection of vulnerable plaque by nis
Date: Wed Sep 14 3:35

Detection of vp with spectroscopy
Date: Wed Sep 14 3:35

Definition of vulnerable plaque atlanta
Date: Wed Sep 14 3:35

Detection of vp by mri after spio maziar
Date: Wed Sep 14 3:35

Detection of production preliminary
Date: Wed Sep 14 3:35

Detecting acute coronary syndrome
Date: Wed Sep 14 3:35

Detection of production of reactive oxygen
Date: Wed Sep 14 3:35

Dekorte
Date: Wed Sep 14 3:35

Definitions of artereial remodeling
Date: Wed Sep 14 3:35

Definition of vulnerable plaque naghavi- thi
Date: Wed Sep 14 3:35

Definitions of arterial remodeling
Date: Wed Sep 14 3:35

Damaged myocardium
Date: Wed Sep 14 3:35

Carotid mri images
Date: Tue Sep 13 2:39

Ca cvpr dec12
Date: Tue Sep 13 2:39

Carotid array coil 2(1)
Date: Tue Sep 13 2:39

Braunwald
Date: Tue Sep 13 2:39

Carotid array coil 3(1)
Date: Tue Sep 13 2:39

Barth imt
Date: Tue Sep 13 2:39

Contrast enhanced mri of the vp black or white
Date: Tue Sep 13 2:07

Contrast enhanced mri of vulnerable plaque black or white
Date: Tue Sep 13 2:07

Cell culture study
Date: Tue Sep 13 2:07

Carotid atherosclerotic lesion models for mri endpoints insull
Date: Tue Sep 13 2:07

Carotid array coil 1
Date: Tue Sep 13 2:07

Can you inherit a carotid plaque
Date: Tue Sep 13 2:07

Capri
Date: Tue Sep 13 2:07

Cardiac petct ahmed tawakol
Date: Tue Sep 13 2:07

Budoff
Date: Tue Sep 13 2:07

Buckymedicine
Date: Tue Sep 13 2:07

Budoff shape-1105
Date: Tue Sep 13 2:07

Bradford hill rules
Date: Tue Sep 13 2:07

Boyd2002
Date: Tue Sep 13 2:07

Blankenberg
Date: Tue Sep 13 2:07

Biodistribution of spio in apo e deficient mice
Date: Tue Sep 13 2:07

Biomarkers angiography2
Date: Tue Sep 13 2:07

Boston sci
Date: Tue Sep 13 2:07

Bio distribution of feridex in.ppt11
Date: Tue Sep 13 2:07

Biodistribution of cns in apo e deficient mice
Date: Tue Sep 13 2:07

Berk
Date: Tue Sep 13 2:07

Basic molecular genetic studies in atherosclerosis
Date: Tue Sep 13 2:07

Berman shape 05 fin
Date: Tue Sep 13 2:07

Betasound
Date: Tue Sep 13 2:07

Becker
Date: Tue Sep 13 2:07

Autoimmune disease
Date: Tue Sep 13 2:07

Badimon
Date: Tue Sep 13 2:07

Atherothrombosis
Date: Tue Sep 13 2:07

Badimon vp-05-jjb
Date: Tue Sep 13 2:07

Atherosclerotic plaque, temperature, ph and lactate
Date: Tue Sep 13 2:07

Atherosclerotic plaque
Date: Tue Sep 13 2:07

Atherosclerosis, an autoimmune disease
Date: Tue Sep 13 2:07

Atherosclerosis and its consequences (plaque rupture and
Date: Tue Sep 13 2:07

Atherosclerosis, an autoimmune disease 2
Date: Tue Sep 13 2:07

Atherosclerosis an autoimmune disease
Date: Tue Sep 13 2:07

Atherosclerosis an autoimmune disease
Date: Tue Sep 13 2:07

Asme05 ibis
Date: Tue Sep 13 1:53

Atalar
Date: Tue Sep 13 1:53

Arterial remodeling in stable versus unstable coronary syndromes
Date: Tue Sep 13 1:53

Arterial remodeling in st vs unst cs
Date: Tue Sep 13 1:53

Arterial remodeling in st vs. unst coronary synd schoenhagen1
Date: Tue Sep 13 1:53

Arterial remodeling paul sch
Date: Tue Sep 13 1:53

Armstrong
Date: Tue Sep 13 1:53

Aortic ulcer intramural hematoma aortic dissection
Date: Tue Sep 13 1:53

Antrin (motexafin lutetium) photoangioplasty
Date: Tue Sep 13 1:53

Ah atk2
Date: Tue Sep 13 1:53

Aeha multipeptide and passive
Date: Tue Sep 13 1:53

Angioscopy
Date: Tue Sep 13 1:53

Allison,james)
Date: Tue Sep 13 1:53

Anatomy and function of the coronary arteries
Date: Tue Sep 13 1:53

Airaksinen
Date: Tue Sep 13 1:53

Aha periadventitial fat
Date: Tue Sep 13 1:53

Aha 2009 v_plaque_characterization
Date: Tue Sep 13 1:53

Aha 2004-no-6-ather.vp,vp-15'
Date: Tue Sep 13 1:53

Aha 2005 crp cost effectiveness
Date: Tue Sep 13 1:53

Aha 2001 presentation maziar
Date: Tue Sep 13 1:53

Aha 2 mr lipid
Date: Tue Sep 13 1:53

Aeha2004 crp lppla2newtemplate-koenig
Date: Tue Sep 13 1:53

Aha2001
Date: Tue Sep 13 1:53

Aeha -aha symposium-nov-2005-short
Date: Tue Sep 13 1:53

Aeha muller 2
Date: Tue Sep 13 1:53

Aeha immune mechanisms in atherosclerosis
Date: Tue Sep 13 1:53

Aeha cea- shaw
Date: Tue Sep 13 1:53

Aeha aha 2002 poster
Date: Tue Sep 13 1:53

Aeha2004 crp lppla2newtemplate
Date: Tue Sep 13 1:53

Adventitial fat presentation
Date: Tue Sep 13 1:53

Adeli 25 28
Date: Tue Sep 13 1:53

Adventitial fat macrophage density a potential new marker of vulnerability
Date: Tue Sep 13 1:53

Acidic p h and atherosclerosis
Date: Tue Sep 13 1:53

Adeli 29 38
Date: Tue Sep 13 1:53

Accmacrophagesword
Date: Tue Sep 13 1:53

Adeli 21 24
Date: Tue Sep 13 1:53

Adeli 9 20
Date: Tue Sep 13 1:53

Adeli 1 8
Date: Tue Sep 13 1:53

Acute coronary syndrome
Date: Tue Sep 13 1:53

Achenbach
Date: Tue Sep 13 1:53

Accv porg
Date: Tue Sep 13 1:53

Ac cculprit
Date: Tue Sep 13 1:53

Acc vp-org 3-02 stone
Date: Tue Sep 13 1:53

Acc v porg
Date: Tue Sep 13 1:53

Acc v porg becker
Date: Tue Sep 13 1:53

Acc 2005-1, v pl-vp
Date: Tue Sep 13 1:53

Acc presentation macrophage (1)
Date: Tue Sep 13 1:53

Acc presentation lipid coated(2)
Date: Tue Sep 13 1:53

SHAPE Presentations 2

Barth imt
Date: Wed Oct 5 21:20

Braunwald
Date: Wed Oct 5 21:20

Acc vp-org 3-02 stone
Date: Tue Oct 4 14:50

101205 shape aha 2005 f
Date: Tue Oct 4 14:50

Acc v porg becker
Date: Tue Oct 4 14:50

Acc 2005-1, v pl-vp
Date: Tue Oct 4 14:50

Acc presentation macrophage (1)
Date: Tue Oct 4 14:50

Acc v porg
Date: Tue Oct 4 14:50

Acc presentation (1)
Date: Tue Oct 4 14:50

Ac cculprit
Date: Tue Oct 4 14:50

Acc presentation lipid coated(2)
Date: Tue Oct 4 14:50

Acc 2002 microarray mehran for print
Date: Tue Oct 4 14:50

Acc booth inventory
Date: Tue Oct 4 14:50

Acc 04 vuln pt
Date: Tue Oct 4 14:50

Acc 2002 mehran for print
Date: Tue Oct 4 14:50

Acc2002 thermography
Date: Tue Oct 4 14:50

A20 gene
Date: Tue Oct 4 14:50

#1 killer of human beings in the 21st century
Date: Tue Oct 4 14:50

A20 is an atherosclerosis
Date: Tue Oct 4 14:50

103100
Date: Tue Oct 4 14:50

259 crp as a risk factor
Date: Tue Oct 4 14:50

511 first steps towards understanding
Date: Tue Oct 4 14:50

1688 azadpour 3 12 02
Date: Tue Oct 4 14:50

1031 talk2
Date: Tue Oct 4 14:50

510 does lxr links lipid metabolism to inflammation, or ppar
Date: Tue Oct 4 14:50

512 low t3 syndrome
Date: Tue Oct 4 14:50

509 chromosome 6p linked to high hdl
Date: Tue Oct 4 14:50

508 search for genomic and proteomic risk factors and protective factors associated with coronary heart disease
Date: Tue Oct 4 14:50

507 stenosis severity and risk benefit
Date: Tue Oct 4 14:50

506 what is the link between infection and cardiovascular events
Date: Tue Oct 4 14:50

505 definitions of arterial remodeling in post mortem and intravascular ultrasound research pasterkamp2
Date: Tue Oct 4 14:50

504 percutaneouse coronary intervention
Date: Tue Oct 4 14:50

503 troponin t and quantitative st segment depression
Date: Tue Oct 4 14:50

502 nmr relaxation times
Date: Tue Oct 4 14:50

260 mri system block diagram
Date: Tue Oct 4 14:50

253 endothelial dysfunction
Date: Tue Oct 4 14:50

501 autoimmune disease
Date: Tue Oct 4 14:50

258 dr renu virmani
Date: Tue Oct 4 14:50

261 molecular genetics and micro arrays
Date: Tue Oct 4 14:50

248 carotid atherosclerotic lesion models
Date: Tue Oct 4 14:50

257 inhibition of atherosclerosis in mice
Date: Tue Oct 4 14:50

256 spatial encoding part 2
Date: Tue Oct 4 14:50

254 nanotechnology
Date: Tue Oct 4 14:50

255 in vivo coronary sinus thermography
Date: Tue Oct 4 14:50

252 statin therapy influence on coronary calcification
Date: Tue Oct 4 14:50

250 patients with very abnormal test results
Date: Tue Oct 4 14:50

249 the most cost effective therapy
Date: Tue Oct 4 14:50

251 computed tomographic coronary artery calcium
Date: Tue Oct 4 14:50

242 lipid lowering
Date: Tue Oct 4 14:50

245 mri scanner
Date: Tue Oct 4 14:50

246 recombinant apolipoprotein ai milano
Date: Tue Oct 4 14:50

239 coronary artery calcium
Date: Tue Oct 4 14:50

247 ebct vs conventional risk factors
Date: Tue Oct 4 14:50

243 b cell
Date: Tue Oct 4 14:50

244 importance of vascular remodelling
Date: Tue Oct 4 14:50

237 vulnerable plaque in esc 2002
Date: Tue Oct 4 14:50

238 carotid array coil
Date: Tue Oct 4 14:50

241 genetic influence on carotid atherosclerosis
Date: Tue Oct 4 14:50

240 spatial encoding
Date: Tue Oct 4 14:50

235 does cd40 link atherosclerosis to thrombosis
Date: Tue Oct 4 14:50

233 cd40
Date: Tue Oct 4 14:50

234 aha 2002 guideline, 1997 or 2002
Date: Tue Oct 4 14:50

236 complement inhibitor
Date: Tue Oct 4 14:50

224 k ras polymorphism in cancer, for atherosclerosis
Date: Tue Oct 4 14:50

232 ptx3 or crp
Date: Tue Oct 4 14:50

229 propagermanium
Date: Tue Oct 4 14:50

231 genetic marker(s) of mi
Date: Tue Oct 4 14:50

230 plaque crp or myocardial crp
Date: Tue Oct 4 14:50

227 which serum should be used
Date: Tue Oct 4 14:50

228 crp, is it a risk factor not a risk marker
Date: Tue Oct 4 14:50

225 animal models of heart attack part 2
Date: Tue Oct 4 14:50

226 statins are overrated
Date: Tue Oct 4 14:50

214 how can calcium score improve your practice
Date: Tue Oct 4 14:50

222 animal models of heart attack
Date: Tue Oct 4 14:50

220 statin therapy and coronary calcification
Date: Tue Oct 4 14:50

221 images of 3 mice
Date: Tue Oct 4 14:50

223 edta chelating therapy
Date: Tue Oct 4 14:50

218 pharmacologic stabilization of vulnerable plaque
Date: Tue Oct 4 14:50

219 coronary autoregulation in vivo
Date: Tue Oct 4 14:50

216 elastography using ivus
Date: Tue Oct 4 14:50

215 antibio
Date: Tue Oct 4 14:50

213 oral apo ai mimetic peptide for reduction of atherosclerosis
Date: Tue Oct 4 14:50

217 c reactive protein
Date: Tue Oct 4 14:50

212 basic molecular genetic studies in atherosclerosis
Date: Tue Oct 4 14:50

211 statin therapy
Date: Tue Oct 4 14:50

209 trans blood vision™
Date: Tue Oct 4 14:50

208 peter libby
Date: Tue Oct 4 14:50

210 atherosclerosis, is it an autoimmune disease
Date: Tue Oct 4 14:50

204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques
Date: Tue Oct 4 14:50

207 progress with the calibration of a 3 fr near infrared catheter
Date: Tue Oct 4 14:50

202 vp watch of the year 2002
Date: Tue Oct 4 14:50

205 macrophage apoptosis
Date: Tue Oct 4 14:50

206 crp lowering or crp guided trial
Date: Tue Oct 4 14:50

203 pathologic substrate of coronary plaque erosion
Date: Tue Oct 4 14:50

201 metabolic dyslipidemia
Date: Tue Oct 4 14:50

200 is coated stent the answer
Date: Tue Oct 4 14:50

199 plaque severity and coronary occlusion
Date: Tue Oct 4 14:50

198 pulse sequences
Date: Tue Oct 4 14:50

197 reducing atherosclerosis in mice
Date: Tue Oct 4 14:50

196 new thermography catheters
Date: Tue Oct 4 14:50

191 spio and t2 effect
Date: Tue Oct 4 14:50

195 hepatic synthesis and secretion of vldl
Date: Tue Oct 4 14:50

194 anatomy and function of the coronary arteries
Date: Tue Oct 4 14:50

193 apo b48 secretion and regulation
Date: Tue Oct 4 14:50

192 pericardioscopy and pericardial biopsy
Date: Tue Oct 4 14:50

184 toll like receptor 4 and atherosclerosis
Date: Tue Oct 4 14:50

190 virus infected monocyes
Date: Tue Oct 4 14:50

189 hsp 65
Date: Tue Oct 4 14:50

187 athero reversa mice
Date: Tue Oct 4 14:50

174 multicontrast mri
Date: Tue Oct 4 14:50

186 4th vulnerable plaque symposium
Date: Tue Oct 4 14:50

165 pressure wire
Date: Tue Oct 4 14:50

185 towards the future cath lab
Date: Tue Oct 4 14:50

170 insulin signaling & vldl overproduction
Date: Tue Oct 4 14:50

183 postulated mechanisms of insulin resistance
Date: Tue Oct 4 14:50

182 non invasive coronary angiography
Date: Tue Oct 4 14:50

181 cholesterol independent therapeutic effects of hdl
Date: Tue Oct 4 14:50

180 aortic thermography catheter
Date: Tue Oct 4 14:50

178 vaccination against atherosclerosis
Date: Tue Oct 4 14:50

179 chlamydophila pneumoniae
Date: Tue Oct 4 14:50

169 coronary artery surgery study
Date: Tue Oct 4 14:50

177 link between coronary and carotid
Date: Tue Oct 4 14:50

175 tissue contrast
Date: Tue Oct 4 14:50

176 coronary pan artritis
Date: Tue Oct 4 14:50

172 nir spectroscopy
Date: Tue Oct 4 14:50

173 mri guided angioplasty
Date: Tue Oct 4 14:50

151 performance of a localized fiber optic
Date: Tue Oct 4 14:50

171 mm ps the dirty dozen
Date: Tue Oct 4 14:50

168 catheter based detection of vulnerable plaque
Date: Tue Oct 4 14:50

163 infra redx
Date: Tue Oct 4 14:50

167 plaque p h heterogeneity in physiological media
Date: Tue Oct 4 14:50

166 ascorbic acid and wound healing
Date: Tue Oct 4 14:50

164 calcium in atherosclerosis
Date: Tue Oct 4 14:50

162 calcium imaging
Date: Tue Oct 4 14:50

161 oct catheter
Date: Tue Oct 4 14:50

155 dna microarray
Date: Tue Oct 4 14:50

160 5th vulnerable plaque symposium
Date: Tue Oct 4 14:50

158 genomic and proteomic risk factors
Date: Tue Oct 4 14:50

159 spio uptake by macrophages
Date: Tue Oct 4 14:50

157 distribution of coronary stenoses
Date: Tue Oct 4 14:50

156 intravascular elastography
Date: Tue Oct 4 14:50

153 mr imaging of atherosclerosis
Date: Tue Oct 4 14:50

154 plaque rupture definition
Date: Tue Oct 4 14:50

152 spio photographs
Date: Tue Oct 4 14:50

150 sudden pathology of sudden cardiac death
Date: Tue Oct 4 14:50

149 revisiting the basics
Date: Tue Oct 4 14:50

146 animal models of vulnerable plaque
Date: Tue Oct 4 14:50

148 the erythrocyte
Date: Tue Oct 4 14:50

147 vulnerable thrombogenic blood
Date: Tue Oct 4 14:50

143 plaque inflammation spio
Date: Tue Oct 4 14:50

145 intravascular elastography
Date: Tue Oct 4 14:50

144 physics of mri
Date: Tue Oct 4 14:50

142 arterial remodelling in coronary syndromes
Date: Tue Oct 4 14:50

140 mr imaging of fibrin
Date: Tue Oct 4 14:50

141 physics of mri
Date: Tue Oct 4 14:50

139 ebt calcium score
Date: Tue Oct 4 14:50

138 new vp website
Date: Tue Oct 4 14:50

137 inflammatory cells in non ruptured atherosclerotic plaques
Date: Tue Oct 4 14:50

136 framingham model and coronary events
Date: Tue Oct 4 14:50

131 the evolution of coronary atherosclerosis
Date: Tue Oct 4 14:50

135 contrast enhanced mri of vulnerable plaque
Date: Tue Oct 4 14:50

132 gene expression in atherosclerotic plaques
Date: Tue Oct 4 14:50

134 mr contrast agents for vulnerable plaque imaging
Date: Tue Oct 4 14:50

133 testosterone and neo intimal plaque development
Date: Tue Oct 4 14:50

129 inflammation and culprit lesions
Date: Tue Oct 4 14:50

130 mri assessment of human atherosclerotic disease
Date: Tue Oct 4 14:50

125 ct based characterization
Date: Tue Oct 4 14:50

128 apo e deficient mice
Date: Tue Oct 4 14:50

126 micro array study for gene expression
Date: Tue Oct 4 14:50

124 nitrate tolerance
Date: Tue Oct 4 14:50

127 arterial wall injury and temperature
Date: Tue Oct 4 14:50

113 intravascular characterization of atheroscleotic lesions
Date: Tue Oct 4 14:50

123 coronary dialsysis
Date: Tue Oct 4 14:50

120 mr imaging for the evaluation of carotid atherosclerosis
Date: Tue Oct 4 14:50

122 drug eluting stents
Date: Tue Oct 4 14:50

121 non invasive imaging of coronary arteries
Date: Tue Oct 4 14:50

118 cell culture study
Date: Tue Oct 4 14:50

119 carotid array coil
Date: Tue Oct 4 14:50

112 macrophage uptake of cns1 1 d
Date: Tue Oct 4 14:50

114 evaluation of atherosclerotic plaque
Date: Tue Oct 4 14:50

117 mr images of human carotid arteries
Date: Tue Oct 4 14:50

116 stabilization of vulnerable plaques
Date: Tue Oct 4 14:50

115 genomic and proteomic screen
Date: Tue Oct 4 14:50

109 anatomy of the atherosclerotic plaque
Date: Sun Oct 2 23:46

110 electron beam tomography
Date: Sun Oct 2 23:46

108 cetp expression
Date: Sun Oct 2 23:46

104 new advances in thermography
Date: Sun Oct 2 23:46

105 nir spectroscopy studies
Date: Sun Oct 2 23:46

107 spio in apo e mouse
Date: Sun Oct 2 23:46

106 detection of crp
Date: Sun Oct 2 23:46

103 in vivo mri of thrombi
Date: Sun Oct 2 23:46

082 smoking and plaque inflammation
Date: Sun Oct 2 23:46

100 non enhancement mri of rabbit
Date: Sun Oct 2 23:46

102 hot plaque
Date: Sun Oct 2 23:46

101 adventitial fat macrophage density
Date: Sun Oct 2 23:46

099 inhibitory effect on arterial injury
Date: Sun Oct 2 23:46

098 red wine and heart disease
Date: Sun Oct 2 23:46

097 atherosclerotic lesions have regions of low p h
Date: Sun Oct 2 23:46

094 spectroscopic fiber optic catheter
Date: Sun Oct 2 23:46

095 thermography idenitfying vulnerable plaques
Date: Sun Oct 2 23:46

091 vascular dysfunction in hypercholesterolemic rabbits
Date: Sun Oct 2 23:46

093 multi slice fast ct
Date: Sun Oct 2 23:46

096 mri imaging of atherosclerosis using spio
Date: Sun Oct 2 23:46

092 il18 and il18 bp in atherosclerosis
Date: Sun Oct 2 23:46

089 intravascular magnetic resonance imaging
Date: Sun Oct 2 23:46

090 carotid atherosclerotic lesion model
Date: Sun Oct 2 23:46

088 optical coherence tomography
Date: Sun Oct 2 23:46

087 mri of atherosclerotic plaque in apo e ko mice
Date: Sun Oct 2 23:46

078 infrared spectroscopy of atherosclerotic plaque
Date: Sun Oct 2 23:46

083 non invasive imaging of the vulnerable plaque
Date: Sun Oct 2 23:46

086 unstable angina, lad stenosis
Date: Sun Oct 2 23:46

085 introduction to nuclear magnetic resonance
Date: Sun Oct 2 23:46

084 biodistribution of spio in apo e mouse
Date: Sun Oct 2 23:46

081 carotid artery plaque
Date: Sun Oct 2 23:46

080 intravascular micro bolometer catheter
Date: Sun Oct 2 23:46

077 intravascular ultrasound for plaque characterization
Date: Sun Oct 2 23:46

079 monocyte recruitment into atherosclerotic plaques
Date: Sun Oct 2 23:46

076 cardiac magnetic resonance imaging
Date: Sun Oct 2 23:46

074 influenza infection effects
Date: Sun Oct 2 23:46

075 immune modulation
Date: Sun Oct 2 23:46

073 collagenases vs collagen
Date: Sun Oct 2 23:46

072 ct angiography
Date: Sun Oct 2 23:46

071 carotid array coil
Date: Sun Oct 2 23:46

070 visualization of atherosclerotic vulnerable plaque
Date: Sun Oct 2 23:46

059 can oct catheter see plaque macrophages
Date: Sun Oct 2 23:46

068 from vulnerable plaque to vulnerable patient
Date: Sun Oct 2 23:46

069 thermography
Date: Sun Oct 2 23:46

067 the holy grail of cardiology
Date: Sun Oct 2 23:46

066 protein structure as a target for ligand design
Date: Sun Oct 2 23:46

065 association for eradication of heart attack
Date: Sun Oct 2 23:46

064 vulnerable thrombogenic blood
Date: Sun Oct 2 23:46

063 plaque characterization with oct
Date: Sun Oct 2 23:46

062 pathologic study of the effect of spio injection
Date: Sun Oct 2 23:46

058 optical coherence tomography
Date: Sun Oct 2 23:46

061 a nano mega initiative
Date: Sun Oct 2 23:46

060 coronary atherosclerosis with multislice ct
Date: Sun Oct 2 23:46

057 coronary endothelial shear stress profiling
Date: Sun Oct 2 23:46

056 extra mri images
Date: Sun Oct 2 23:46

055 mri applications in cardiovascular medicine
Date: Sun Oct 2 23:46

054 vulnerable plaques and vulnerable patients
Date: Sun Oct 2 23:46

053 histologic evidence of spio accumulation in vulnerable plaques
Date: Sun Oct 2 23:46

049 macrophage induced proteolysis
Date: Sun Oct 2 23:46

052 non invasive high resolution detection
Date: Sun Oct 2 23:46

051 plaque inflam detection in atherosclerotic rabbits
Date: Sun Oct 2 23:46

050 periadventitial fat
Date: Sun Oct 2 23:46

048 adventitial fat presentation
Date: Sun Oct 2 23:46

047 bio distribution of feridex in
Date: Sun Oct 2 23:46

046 respiratory infection of apoe ko mice and plaque inflammation
Date: Sun Oct 2 23:46

043 thermo elastography
Date: Sun Oct 2 23:46

045 how can we identify the plaque at risk of rupture or thrombosis
Date: Sun Oct 2 23:46

042 introducing a novel model
Date: Sun Oct 2 23:46

044 mice mri
Date: Sun Oct 2 23:46

041 transgenic cetp dahl salt sensitive (tg53) rat model
Date: Sun Oct 2 23:46

040 center for vulnerable plaque research
Date: Sun Oct 2 23:46

036 dogs heart
Date: Sun Oct 2 23:46

038 tct arrow pics, landscape
Date: Sun Oct 2 23:46

039 mr contrast agents for vulnerable plaque imaging
Date: Sun Oct 2 23:46

037 association for eradication of heart attack
Date: Sun Oct 2 23:46

035 respiratory infection of apo e ko mice
Date: Sun Oct 2 23:46

034 everybody has atherosclerosis
Date: Sun Oct 2 23:46

033 uptakes of spio by murine
Date: Sun Oct 2 23:46

7
Date: Sun Oct 2 23:46

032 hossein eftekhari,md
Date: Sun Oct 2 23:46

031
Date: Sun Oct 2 23:46

8
Date: Sun Oct 2 23:46

5
Date: Sun Oct 2 23:46

4th vulnerable plaque symposium
Date: Sun Oct 2 23:46

3rd vulnerable plaque rumberger 3 16-02 4
Date: Sun Oct 2 23:46

4
Date: Sun Oct 2 23:46

3rd vulnerable plaque rumberger 3 16-02 4
Date: Sun Oct 2 23:46

3rd vulnerable plaque rumberger 3 16-02 1
Date: Sun Oct 2 23:46

3rd vulnerable plaque rumberger 3 16-02 3
Date: Sun Oct 2 23:46

3rd vulnerable plaque rumberger 3 16-02 3
Date: Sun Oct 2 23:46

3rd vulnerable plaque rumberger 3 16-02 1
Date: Sun Oct 2 23:46

1
Date: Sun Oct 2 23:46

3rd vulnerable plaque rumberg 3 16-02 2
Date: Sun Oct 2 23:46

3rd vulnerable plaque rumberg 3 16-02 2
Date: Sun Oct 2 23:46

3rd vp symposium jang
Date: Sun Oct 2 23:46

3rd vp symposium jang
Date: Sun Oct 2 23:46

3 mouse
Date: Sun Oct 2 23:46

3rd vp symposium herrera
Date: Sun Oct 2 23:46

1 spio-mri studies by dr naghavi - amersham oct 2003
Date: Sun Oct 2 23:46

2
Date: Sun Oct 2 23:46

Single Session of MR Coronary Angiography and Myocardial Perfusion Imaging
Date: Fri May 9 14:25

Medication non-adherence is associated with a broad range of adverse outcomes in patients with coronary artery disease
Date: Fri May 9 14:25

Turbulent blood flow plays an essential localizing role in the development of atherosclerotic lesions in experimentally-induced hypercholesterolemia in rats
Date: Fri May 9 14:25

Predictors of persistence with antihypertensive therapy: results from the NHANES
Date: Fri May 9 14:25

Phosphorus levels are associated with subclinical atherosclerosis in the general population
Date: Fri May 9 14:24

Cigarette smoking, systolic blood pressure, and cardiovascular diseases in the asia-pacific region
Date: Fri May 9 14:24

The Impact of carotid plaque screening on motivation for smoking cessation and knowledge retention about atherosclerosis
Date: Fri May 9 14:24

Coronary artery disease among asymptomatic diabetic and non-diabetic patients undergoing coronary CT angiography
Date: Fri May 9 14:04

No correlation and low agreement of imaging and inflammatory atherosclerosis’ markers in familial hypercholesterolemia
Date: Fri May 9 14:04

Incremental predictive value of vascular assessments combined with the Framingham Risk Score for prediction of coronary events in subjects of low intermediate risk
Date: Fri May 9 14:04

Nonalcoholic fatty liver disease and carotid atherosclerosis in children
Date: Fri May 9 14:04

Tasneem Naqvi, M.D

Tasneem

Director Echocardiography; Senior Associate Consultant, Mayo Clinic, Scottsdale, AZ

 Like
 Tweet
 +1
 Pin it

.

CONTACT SHAPE

Society for Heart Attack
Prevention and Eradication
Palo Alto Square
3000 El Camino Real, Suite 200
Palo Alto, CA 94306
Tel:-877-SHAPE11 (1-877-742-7311)
Email: info@shapesociety.org

THE SHAPE BOOK

Follow us

SHAPE supports
No More Broken Hearts

ShapeSociety, Copyright 2022

Top ↑

Follow us:     